MIL-OSI USA: Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products
Source: US Department of Health and Human Services – 3 Among the biggest challenges health care providers and patients face are shortages of medically necessary medications. These shortages greatly impact patient treatment options and require practitioners to make difficult decisions that can compromise care, such as rationing supplies or using less desirable, but more readily […]
Read More →MIL-OSI USA: Learn more >> about CMS Statement: Administrator Verma Applauds Greater Access to Health Coverage under New Rule
Source: US Department of Health and Human Services Press releases Date 2018-06-19 Title CMS Statement: Administrator Verma Applauds Greater Access to Health Coverage under New Rule Contact press@cms.hhs.gov CMS Statement: Administrator Verma Applauds Greater Access to Health Coverage under New Rule “The Trump Administration took important steps today to help small business employees and their […]
Read More →MIL-OSI USA: Various Aortic Endovascular Graft Systems: Letter to Health Care Providers – UPDATE on Type III Endoleaks
Source: US Department of Health and Human Services – 3 [Posted 06/19/2018] AUDIENCE: Risk Manager, Surgery, Patient, Cardiology ISSUE: The FDA continues to evaluate information from several sources and based on new information, the Endologix AFX with Strata device is at greater risk for a Type III endoleak compared to other endovascular AAA graft systems. […]
Read More →MIL-OSI USA: Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply
Source: US Department of Health and Human Services – 3 In the U.S., we enjoy one of the safest food supplies in the world. The FDA takes its responsibility to protect the U.S. food supply very seriously. And while we work diligently to prevent accidental contaminations, it’s also our duty to take measures to protect […]
Read More →MIL-OSI USA: Methadone and buprenorphine reduce risk of death after opioid overdose
Source: US Department of Health and Human Services – 2 News Release Tuesday, June 19, 2018 NIH research confirms effective treatments for opioid use disorder are underutilized. A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions […]
Read More →MIL-OSI USA: NIH to end funding for Moderate Alcohol and Cardiovascular Health trial
Source: US Department of Health and Human Services – 2 News Release Friday, June 15, 2018 The National Institutes of Health plans to end funding to the Moderate Alcohol and Cardiovascular Health (MACH) trial. The decision is based on concerns about the study design that cast doubt on its ultimate credibility. This includes whether the […]
Read More →MIL-OSI USA: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Anna Abram on emerging food innovation, “cultured” food products
Source: US Department of Health and Human Services – 3 Food safety is at the core of the agency’s mission to protect and promote public health for our nation’s consumers. We take seriously our commitment to the consumers and industry who look to the FDA for important guidance when it comes to our nation’s food […]
Read More →MIL-OSI USA: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals – Adverse Events After Receiving Eye Injections
Source: US Department of Health and Human Services – 3 [Posted 06/14/2018] AUDIENCE: Patient, Health Professional, Eye Care, Risk Manager ISSUE: At least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients reportedly experienced various symptoms, including vision impairment, poor night vision, loss […]
Read More →MIL-OSI USA: Early-stage Respiratory Syncytial Virus vaccine trial begins
Source: US Department of Health and Human Services – 2 News Release Thursday, June 14, 2018 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus (RSV). The Phase 1 study will enroll a […]
Read More →MIL-OSI USA: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food
Source: US Department of Health and Human Services – 3 Increasingly, Americans are seeking healthy food options, whether they’re eating out or dining at home. Their ability to choose healthy foods starts with their ability to understand what’s in their food in the first place. Public surveys suggest that Americans want food makers to be […]
Read More →